Format

Send to

Choose Destination
Front Immunol. 2017 Apr 24;8:453. doi: 10.3389/fimmu.2017.00453. eCollection 2017.

Helminth Immunomodulation in Autoimmune Disease.

Author information

1
School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
2
Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia.
3
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
4
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
5
School of Medicine, The University of Queensland, Brisbane, QLD, Australia.

Abstract

Helminths have evolved to become experts at subverting immune surveillance. Through potent and persistent immune tempering, helminths can remain undetected in human tissues for decades. Redirecting the immunomodulating "talents" of helminths to treat inflammatory human diseases is receiving intensive interest. Here, we review therapies using live parasitic worms, worm secretions, and worm-derived synthetic molecules to treat autoimmune disease. We review helminth therapy in both mouse models and clinical trials and discuss what is known on mechanisms of action. We also highlight current progress in characterizing promising new immunomodulatory molecules found in excretory/secretory products of helminths and their potential use as immunotherapies for acute and chronic inflammatory diseases.

KEYWORDS:

autoimmunity; excretory/secretory products; helminthic therapy; immunomodulation; immunotherapy

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center